EU set to back Novavax Covid vaccine
THE HAGUE, Dec 20, 2021 (AFP) – The EU’s drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy. Novavax’s jab, a protein-based vaccine of the kind used around the world to protect against many childhood illnesses, would be … Read more
